{"id":59910,"date":"2024-08-27T22:05:58","date_gmt":"2024-08-27T20:05:58","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/adicet-bio-to-present-at-the-h-c-wainwright-26th-annual-global-investment-conference\/"},"modified":"2024-08-27T22:05:58","modified_gmt":"2024-08-27T20:05:58","slug":"adicet-bio-to-present-at-the-h-c-wainwright-26th-annual-global-investment-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/adicet-bio-to-present-at-the-h-c-wainwright-26th-annual-global-investment-conference\/","title":{"rendered":"Adicet Bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference"},"content":{"rendered":"<div>\n<p>REDWOOD CITY, Calif. &amp; BOSTON&#8211;(BUSINESS WIRE)&#8211;Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that Chen Schor, President and Chief Executive Officer, will present at the H.C. Wainwright 26th Annual Global Investment Conference being held from September 9-11, 2024 in New York.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20240827091988\/en\/1339314\/5\/adicet_logo_500x300_%28002%29_%28004%29.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240827091988\/en\/1339314\/22\/adicet_logo_500x300_%28002%29_%28004%29.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20240827091988\/en\/1339314\/5\/adicet_logo_500x300_%28002%29_%28004%29.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240827091988\/en\/1339314\/21\/adicet_logo_500x300_%28002%29_%28004%29.jpg\"><\/a><\/p>\n<p>\nDetails of the event are as follows:<br \/>\n<br \/>Date: Tuesday, September 10, 2024<br \/>\n<br \/>Time: 2:30 p.m. ET<\/p>\n<p>\nThe live audio webcast can be accessed on the Investors section of Adicet Bio\u2019s website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.adicetbio.com&amp;esheet=54114158&amp;newsitemid=20240827091988&amp;lan=en-US&amp;anchor=http%3A%2F%2Fwww.adicetbio.com&amp;index=1&amp;md5=a2c6382259eff7144b202635c70d0a96\" rel=\"nofollow noopener\" shape=\"rect\">http:\/\/www.adicetbio.com<\/a>. An archived replay will be available for 30 days following the presentation.<\/p>\n<p>\n<b>About Adicet Bio, Inc.<\/b><\/p>\n<p>\nAdicet Bio, Inc. is a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. Adicet is advancing a pipeline of \u201coff-the-shelf\u201d gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. For more information, please visit our website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.adicetbio.com&amp;esheet=54114158&amp;newsitemid=20240827091988&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.adicetbio.com&amp;index=2&amp;md5=26adbf698682121e6efc733ea8ae5669\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.adicetbio.com<\/a>.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Adicet Bio, Inc.<\/b><br \/><b>Investor and Media Contacts<\/b><\/p>\n<p>\n<b>Investors:<\/b><br \/>Anne Bowdidge<br \/>\n<br \/><a target=\"_blank\" href=\"m&#97;&#105;&#x6c;&#x74;&#x6f;:&#97;&#98;&#x6f;&#x77;&#x64;id&#103;&#x65;&#x40;&#x61;di&#99;&#101;&#x74;&#x62;&#x69;o&#46;&#99;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#97;&#x62;o&#x77;&#x64;&#105;&#x64;g&#101;&#x40;&#97;&#x64;i&#99;&#x65;t&#x62;i&#111;&#x2e;c&#x6f;&#x6d;<\/a><\/p>\n<p>\nJanhavi Mohite<br \/>\n<br \/>Precision AQ<br \/>\n<br \/>212-362-1200<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;i&#x6c;&#x74;&#111;&#x3a;j&#x61;&#x6e;&#104;&#x61;v&#x69;&#x2e;&#109;&#x6f;h&#x69;&#x74;&#101;&#x40;p&#x72;&#x65;&#99;&#x69;s&#x69;&#x6f;&#110;&#x61;q&#x2e;&#x63;&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">jan&#104;&#97;&#118;&#x69;&#x2e;&#x6d;&#x6f;&#x68;&#x69;te&#64;&#112;&#114;&#101;&#99;&#x69;&#x73;&#x69;&#x6f;&#x6e;&#x61;q&#46;c&#111;&#109;<\/a><\/p>\n<p>\n<b>Media:<\/b><br \/>Kerry Beth Daly<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#x69;&#108;&#x74;&#x6f;:&#x6b;&#x62;d&#97;&#x6c;y&#64;&#x61;d&#105;&#x63;e&#116;&#x62;i&#111;&#x2e;&#x63;&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x6b;&#98;d&#x61;&#108;&#121;&#x40;&#x61;&#100;i&#x63;&#101;t&#x62;&#x69;&#111;&#46;&#x63;&#111;m<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>REDWOOD CITY, Calif. &amp; BOSTON&#8211;(BUSINESS WIRE)&#8211;Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that Chen Schor, President and Chief Executive Officer, will present at the H.C. Wainwright 26th Annual Global Investment Conference being held from September 9-11, &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/adicet-bio-to-present-at-the-h-c-wainwright-26th-annual-global-investment-conference\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-59910","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Adicet Bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/adicet-bio-to-present-at-the-h-c-wainwright-26th-annual-global-investment-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Adicet Bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"REDWOOD CITY, Calif. &amp; BOSTON&#8211;(BUSINESS WIRE)&#8211;Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that Chen Schor, President and Chief Executive Officer, will present at the H.C. Wainwright 26th Annual Global Investment Conference being held from September 9-11, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/adicet-bio-to-present-at-the-h-c-wainwright-26th-annual-global-investment-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-27T20:05:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20240827091988\/en\/1339314\/22\/adicet_logo_500x300_%28002%29_%28004%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adicet-bio-to-present-at-the-h-c-wainwright-26th-annual-global-investment-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adicet-bio-to-present-at-the-h-c-wainwright-26th-annual-global-investment-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Adicet Bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference\",\"datePublished\":\"2024-08-27T20:05:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adicet-bio-to-present-at-the-h-c-wainwright-26th-annual-global-investment-conference\\\/\"},\"wordCount\":214,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adicet-bio-to-present-at-the-h-c-wainwright-26th-annual-global-investment-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240827091988\\\/en\\\/1339314\\\/22\\\/adicet_logo_500x300_%28002%29_%28004%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adicet-bio-to-present-at-the-h-c-wainwright-26th-annual-global-investment-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adicet-bio-to-present-at-the-h-c-wainwright-26th-annual-global-investment-conference\\\/\",\"name\":\"Adicet Bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adicet-bio-to-present-at-the-h-c-wainwright-26th-annual-global-investment-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adicet-bio-to-present-at-the-h-c-wainwright-26th-annual-global-investment-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240827091988\\\/en\\\/1339314\\\/22\\\/adicet_logo_500x300_%28002%29_%28004%29.jpg\",\"datePublished\":\"2024-08-27T20:05:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adicet-bio-to-present-at-the-h-c-wainwright-26th-annual-global-investment-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adicet-bio-to-present-at-the-h-c-wainwright-26th-annual-global-investment-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adicet-bio-to-present-at-the-h-c-wainwright-26th-annual-global-investment-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240827091988\\\/en\\\/1339314\\\/22\\\/adicet_logo_500x300_%28002%29_%28004%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240827091988\\\/en\\\/1339314\\\/22\\\/adicet_logo_500x300_%28002%29_%28004%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adicet-bio-to-present-at-the-h-c-wainwright-26th-annual-global-investment-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Adicet Bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Adicet Bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/adicet-bio-to-present-at-the-h-c-wainwright-26th-annual-global-investment-conference\/","og_locale":"en_US","og_type":"article","og_title":"Adicet Bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Pharma Trend","og_description":"REDWOOD CITY, Calif. &amp; BOSTON&#8211;(BUSINESS WIRE)&#8211;Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that Chen Schor, President and Chief Executive Officer, will present at the H.C. Wainwright 26th Annual Global Investment Conference being held from September 9-11, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/adicet-bio-to-present-at-the-h-c-wainwright-26th-annual-global-investment-conference\/","og_site_name":"Pharma Trend","article_published_time":"2024-08-27T20:05:58+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20240827091988\/en\/1339314\/22\/adicet_logo_500x300_%28002%29_%28004%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/adicet-bio-to-present-at-the-h-c-wainwright-26th-annual-global-investment-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/adicet-bio-to-present-at-the-h-c-wainwright-26th-annual-global-investment-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Adicet Bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference","datePublished":"2024-08-27T20:05:58+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/adicet-bio-to-present-at-the-h-c-wainwright-26th-annual-global-investment-conference\/"},"wordCount":214,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/adicet-bio-to-present-at-the-h-c-wainwright-26th-annual-global-investment-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240827091988\/en\/1339314\/22\/adicet_logo_500x300_%28002%29_%28004%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/adicet-bio-to-present-at-the-h-c-wainwright-26th-annual-global-investment-conference\/","url":"https:\/\/pharma-trend.com\/en\/adicet-bio-to-present-at-the-h-c-wainwright-26th-annual-global-investment-conference\/","name":"Adicet Bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/adicet-bio-to-present-at-the-h-c-wainwright-26th-annual-global-investment-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/adicet-bio-to-present-at-the-h-c-wainwright-26th-annual-global-investment-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240827091988\/en\/1339314\/22\/adicet_logo_500x300_%28002%29_%28004%29.jpg","datePublished":"2024-08-27T20:05:58+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/adicet-bio-to-present-at-the-h-c-wainwright-26th-annual-global-investment-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/adicet-bio-to-present-at-the-h-c-wainwright-26th-annual-global-investment-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/adicet-bio-to-present-at-the-h-c-wainwright-26th-annual-global-investment-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20240827091988\/en\/1339314\/22\/adicet_logo_500x300_%28002%29_%28004%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20240827091988\/en\/1339314\/22\/adicet_logo_500x300_%28002%29_%28004%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/adicet-bio-to-present-at-the-h-c-wainwright-26th-annual-global-investment-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Adicet Bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59910","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=59910"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59910\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=59910"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=59910"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=59910"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}